Quarterly Results

KREBS BIOCHEMICALS & INDUSTRIES LTD.

NSE : KREBSBIOBSE : 524518ISIN CODE : INE268B01013Industry : Pharmaceuticals & DrugsHouse : Private
BSE61.02-2.8 (-4.39 %)
PREV CLOSE ( ) 63.82
OPEN PRICE ( ) 63.82
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 5026
TODAY'S LOW / HIGH ( )60.63 64.00
52 WK LOW / HIGH ( )51.1 93.2
NSE61.45-2.05 (-3.23 %)
PREV CLOSE( ) 63.50
OPEN PRICE ( ) 63.05
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 61.45 (198)
VOLUME 39300
TODAY'S LOW / HIGH( ) 60.35 65.00
52 WK LOW / HIGH ( )50.65 93.95
Quarters
Select year  
( in Million)
Particulars
Dec 2023
Sep 2023
Jun 2023
Mar 2023
Audited / UnAudited
UnAudited
UnAudited
UnAudited
Audited
Net Sales
129.77
148.9
105.81
114.61
Total Expenditure
150.67
157.91
132.01
160.85
PBIDT (Excl OI)
-20.9
-9.00
-26.2
-46.24
Other Income
0.29
1.74
0.38
1.93
Operating Profit
-20.6
-7.27
-25.82
-44.31
Interest
11.86
11.34
10.97
10.28
Exceptional Items
NA
NA
NA
NA
PBDT
-32.46
-18.61
-36.79
-54.59
Depreciation
17.31
17.11
16.53
14.8
Profit Before Tax
-49.77
-35.72
-53.32
-69.39
Tax
NA
NA
NA
NA
Provisions and contingencies
NA
NA
NA
NA
Profit After Tax
-49.77
-35.72
-53.32
-69.39
Extraordinary Items
NA
NA
NA
NA
Prior Period Expenses
NA
NA
NA
NA
Other Adjustments
0.00
0.00
0.00
0.00
Net Profit
-49.77
-35.72
-53.32
-69.39
Equity Capital
215.61
215.61
215.61
215.61
Face Value (IN RS)
10
10
10
10
Reserves
Calculated EPS
-2.30
-1.65
-2.47
-3.21
Calculated EPS (Annualised)
-9.23
-6.62
-9.89
-12.87
No of Public Share Holdings
5876452
5876452
5876452
5877161
% of Public Share Holdings
27.26
27.26
27.26
27.26
 
NA
NA
NA
NA
PBIDTM% (Excl OI)
-16.10
-6.05
-24.76
-40.34
PBIDTM%
-15.87
-4.88
-24.40
-38.66
PBDTM%
-25.01
-12.49
-34.76
-47.63
PBTM%
-38.35
-23.98
-50.39
-60.54
PATM%
-38.35
-23.98
-50.39
-60.54
 
Notes
Notes
Notes
Notes

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.